Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care

Fig. 3

Annual per patient costs of resource use. Annual per patient costs over 24 months of resource use related to COPD among patients adherent to initial LABD therapy (MPR ≥ 80 %). COPD-chronic obstructive pulmonary disease; GP, general practitioner; ICS-inhaled corticosteroid; LABA-long-acting beta2-agonist; LABD-long-acting bronchodilator; LAMA-long-acting muscarinic antagonist; MPR, medication possession ratio

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us